The current FOLD market cap is 3.11B. The company's latest EPS is USD -0.5132 and P/E is -20.54.
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 81.69M | 88.1M | 86.27M | 94.5M | 103.5M |
Operating Income | -33.27M | -40.74M | -37.64M | -17.39M | -15.03M |
Net Income | -33.29M | -55.87M | -52.93M | -43.23M | -21.58M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 182.24M | 260.89M | 305.51M | 329.23M | 399.36M |
Operating Income | -304.04M | -247M | -206.43M | -204.43M | -73.49M |
Net Income | -356.39M | -276.85M | -250.46M | -236.57M | -151.58M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 759.53M | 724.17M | 700.52M | 730.09M | 764.08M |
Total Liabilities | 626.96M | 601.12M | 597.95M | 618.51M | 630.85M |
Total Equity | 132.57M | 123.05M | 102.57M | 111.58M | 133.24M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 850.21M | 886.52M | 905.14M | 724.17M | 777.88M |
Total Liabilities | 373.78M | 600.14M | 597.77M | 601.12M | 617.71M |
Total Equity | 476.43M | 286.38M | 307.37M | 123.05M | 160.17M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -85.8M | -166.58M | -18.07M | -34.2M | -72.55M |
Investing | 159.02M | 92.32M | 36.26M | 86.26M | 122.02M |
Financing | -8.02M | -7.46M | -7.83M | 15.85M | 53.47M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -250.42M | -233.29M | -202.49M | -166.58M | -69.09M |
Investing | 95.15M | -13.58M | 78.76M | 92.32M | 98.06M |
Financing | 217.5M | 262.86M | 212.07M | -7.46M | 61.68M |
Market Cap | 3.11B |
Price to Earnings Ratio | -20.54 |
Price to Sales Ratio | 7.8 |
Price to Cash Ratio | 12.6 |
Price to Book Ratio | 19.44 |
Dividend Yield | - |
Shares Outstanding | 295.38M |
Average Volume (1 week) | 3.23M |
Average Volume (1 Month) | 2.71M |
52 Week Change | -7.95% |
52 Week High | 14.57 |
52 Week Low | 9.70 |
Spread (Intraday) | 0.54 (4.91%) |
Company Name | Amicus Therapeutics Inc |
Address |
1209 orange street wilmington, delaware 19801 |
Website | https://www.amicusrx.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.